{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:29:03Z","timestamp":1788866943186,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.oret.2021.05.007","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T12:20:22Z","timestamp":1620994822000},"page":"e30-e37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-949X","authenticated-orcid":false,"given":"Livia","family":"Lumbroso-Le Rouic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Saint Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Savignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9 J.","family":"Brisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Pierrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"L\u00e9vy-Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-777X","authenticated-orcid":false,"given":"Alexandre","family":"Matet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.oret.2021.05.007_bib1","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1200\/JCO.2000.18.15.2881","article-title":"First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma","volume":"18","author":"Beck","year":"2000","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.oret.2021.05.007_bib2","first-page":"179","article-title":"Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy","volume":"2015","author":"Lumbroso-Le Rouic","year":"2015","journal-title":"Eye"},{"issue":"8","key":"10.1016\/j.oret.2021.05.007_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ophtha.2007.11.009","article-title":"Conservative treatments of intraocular retinoblastoma","volume":"115","author":"Lumbroso-Le Rouic","year":"2008","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.oret.2021.05.007_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.ophtha.2009.12.030","article-title":"Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery)","volume":"117","author":"Abramson","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.oret.2021.05.007_bib5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1371\/journal.pone.0197081","article-title":"Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival","volume":"13","author":"Francis","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.oret.2021.05.007_bib6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.oret.2021.05.007_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","article-title":"The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma","volume":"9","author":"Yamane","year":"2004","journal-title":"Int J Clin Oncol"},{"issue":"12","key":"10.1016\/j.oret.2021.05.007_bib8","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.oret.2021.05.007_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2015.01.017","article-title":"The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan","volume":"122","author":"Francis","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.05.007_bib10","series-title":"Ophthalmology clinics of north america","article-title":"Intraocular retinoblastoma: the case for a new group classification","author":"Murphree","year":"2005"},{"issue":"1","key":"10.1016\/j.oret.2021.05.007_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00247-011-2201-5","article-title":"Guidelines for imaging retinoblastoma: imaging principles and MRI standardization","volume":"42","author":"de Graaf","year":"2012","journal-title":"Pediatr Radiol"},{"issue":"10","key":"10.1016\/j.oret.2021.05.007_bib12","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"issue":"100764","key":"10.1016\/j.oret.2021.05.007_bib13","first-page":"5","article-title":"Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. \"Alive, with good vision and no comorbidity","volume":"73","author":"Munier","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"10.1016\/j.oret.2021.05.007_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044322","article-title":"Combined, sequential intravenous and intra-arterial chemotherapy (bridge chemotherapy) for young infants with retinoblastoma","volume":"7","author":"Gobin","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.oret.2021.05.007_bib15","first-page":"713","article-title":"Determinants of Radiation Dose in Selective Ophthalmic Artery Chemosurgery for Retinoblastoma","volume":"40","author":"Qureshi","year":"2019","journal-title":"Ajnr"},{"issue":"11","key":"10.1016\/j.oret.2021.05.007_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/neurintsurg-2016-012758","article-title":"Selective ophthalmic artery chemosurgery (SOAC) for retinoblastoma: fluoroscopic time and radiation dose parameters. A baseline study","volume":"9","author":"Boddu","year":"2017","journal-title":"J Neurointerv Surg"},{"issue":"9","key":"10.1016\/j.oret.2021.05.007_bib17","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00234-019-02260-7","article-title":"Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact","volume":"61","author":"Guasti","year":"2019","journal-title":"Neuroradiology"},{"issue":"12","key":"10.1016\/j.oret.2021.05.007_bib18","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/neurintsurg-2019-014910","article-title":"Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma","volume":"11","author":"Area","year":"2019","journal-title":"J Neurointerv Surg"},{"issue":"7","key":"10.1016\/j.oret.2021.05.007_bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.oret.2021.05.007_bib20","first-page":"732","article-title":"Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch"},{"issue":"8","key":"10.1016\/j.oret.2021.05.007_bib21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"Munier","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.oret.2021.05.007_bib22","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.oret.2021.05.007_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bjophthalmol-2013-303267","article-title":"Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma","volume":"97","author":"Bracco","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.oret.2021.05.007_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000491580","article-title":"Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience","volume":"5","author":"Dalvin","year":"2019","journal-title":"Ocul Oncol Pathol"},{"issue":"3","key":"10.1016\/j.oret.2021.05.007_bib25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.oret.2021.05.007_bib26","first-page":"1427","article-title":"Intra-arterial Chemotherapy for Retinoblastoma: Report No. 2, Treatment ComplicationsIrradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned?","volume":"128","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.oret.2021.05.007_bib27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ophtha.2018.05.013","article-title":"Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras","volume":"125","author":"Dalvin","year":"2018","journal-title":"Ophthalmology"},{"issue":"17","key":"10.1016\/j.oret.2021.05.007_bib28","article-title":"Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol 2016"},{"issue":"8","key":"10.1016\/j.oret.2021.05.007_bib29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.oret.2021.05.007_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:32Z","timestamp":1762853372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653021001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2468653021001664"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2021.05.007","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Ophthalmic Artery Chemotherapy with Melphalan in the Management of Unilateral Retinoblastoma: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2021.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}